ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.01 and traded as low as $0.0056. ProtoKinetix shares last traded at $0.0056, with a volume of 272,915 shares changing hands.
ProtoKinetix Stock Performance
The business’s fifty day moving average is $0.01 and its 200-day moving average is $0.01.
About ProtoKinetix
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc and changed its name to ProtoKinetix, Incorporated in July 2003.
Featured Articles
- Five stocks we like better than ProtoKinetix
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
- Beyond the AI Trade: 3 Defensive Stocks Built for Stability
- MarketBeat Week in Review – 06/15 – 06/19
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
